We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Phosphate Group Is Key Regulator of Melatonin Metabolism

By Biotechdaily staff writers
Posted on 05 Nov 2003
Researchers studying the sleep-inducing hormone melatonin have developed a method to modify the enzyme responsible for the synthesis of melatonin in order to prevent its degradation.

To study melatonin metabolism in cells, investigators at Johns Hopkins University (Baltimore, MD, USA) modified serotonin N-acetyltransferase (arylalkylamine N-acetyltransferase, AANAT) through the incorporation of a nonhydrolyzable phosphoserine/threonine mimetic, phosphonomethylenealanine (Pma), at position 31 (AANAT-Pma31). More...
The presence of the added chemical group prevented enzymes that normally inactivate AANAT from removing the phosphate at position 31. The presence of the mimetic also improved the enzyme's ability to bind to a protein known as 14-3-3, further increasing the enzyme's stability and delaying its degradation. These findings were published October 26, 2003, in the online edition of Nature Structural Biology.

"We have discovered that addition and removal of the phosphate group at this position is the key step in regulating the enzyme's stability,” explained senior author Dr. Philip Cole, professor of pharmacology and molecular sciences at Johns Hopkins University. "When this phosphate group is present, the enzyme is stable.”




Related Links:
Johns Hopkins University

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Immunofluorescence Analyzer
IFA System
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Photo courtesy of Adobe Stock

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.